-
公开(公告)号:US09642811B2
公开(公告)日:2017-05-09
申请号:US14667826
申请日:2015-03-25
Applicant: SUN PHARMA ADVANCED RESEARCH COMPANY LTD.
IPC: A61K9/28 , A61K9/48 , A61K31/137 , A61K31/5517 , A61K9/20 , A61K31/433 , A61K9/50
CPC classification number: A61K9/2081 , A61K9/2009 , A61K9/2013 , A61K9/2027 , A61K9/2031 , A61K9/2054 , A61K9/2059 , A61K9/2077 , A61K9/2846 , A61K9/4808 , A61K9/485 , A61K9/4858 , A61K9/4866 , A61K9/5026 , A61K31/135 , A61K31/137 , A61K31/167 , A61K31/433 , A61K31/5517 , A61K2300/00
Abstract: An abuse deterrent immediate release biphasic matrix solid dosage form that releases the drug at a desired rate for quick onset of action when a single unit or prescribed units of the dosage form are orally administered but exhibits a reduced rate of release when more than the prescribed number of units, are administered.
-
公开(公告)号:US09980917B2
公开(公告)日:2018-05-29
申请号:US15441712
申请日:2017-02-24
Applicant: SUN PHARMA ADVANCED RESEARCH COMPANY LTD.
IPC: A61K9/48 , A61K31/137 , A61K9/20 , A61K31/135 , A61K31/5517
CPC classification number: A61K9/2081 , A61K9/2009 , A61K9/2013 , A61K9/2027 , A61K9/2031 , A61K9/2054 , A61K9/2059 , A61K9/2077 , A61K9/2846 , A61K9/4808 , A61K9/485 , A61K9/4858 , A61K9/4866 , A61K9/5026 , A61K31/135 , A61K31/137 , A61K31/167 , A61K31/433 , A61K31/5517 , A61K2300/00
Abstract: An abuse deterrent immediate release coated reservoir solid dosage form that releases the drug at a desired rate for quick onset of action when a single unit or prescribed units of the dosage form are orally administered but exhibits a reduced rate of release when more than the prescribed number of units, are administered.
-
公开(公告)号:US09610269B2
公开(公告)日:2017-04-04
申请号:US14107245
申请日:2013-12-16
Applicant: SUN PHARMA ADVANCED RESEARCH COMPANY LTD.
IPC: A61K31/197 , A61K9/00 , A61K9/24 , A61K9/48 , A61K9/50
CPC classification number: A61K31/197 , A61K9/006 , A61K9/0065 , A61K9/209 , A61K9/4866 , A61K9/4891 , A61K9/5047
Abstract: The present invention discloses a method of treating a disease condition susceptible to baclofen therapy, said method comprising orally administering once-a-day in the evening a controlled release drug delivery system comprising baclofen or its pharmaceutically acceptable salt or its derivatives and pharmaceutically acceptable excipients.
-
公开(公告)号:US09616029B2
公开(公告)日:2017-04-11
申请号:US14667834
申请日:2015-03-25
Applicant: SUN PHARMA ADVANCED RESEARCH COMPANY LTD.
IPC: A61K9/28 , A61K9/48 , A61K31/137 , A61K31/5517 , A61K9/20 , A61K31/433 , A61K9/50
CPC classification number: A61K9/2081 , A61K9/2009 , A61K9/2013 , A61K9/2027 , A61K9/2031 , A61K9/2054 , A61K9/2059 , A61K9/2077 , A61K9/2846 , A61K9/4808 , A61K9/485 , A61K9/4858 , A61K9/4866 , A61K9/5026 , A61K31/135 , A61K31/137 , A61K31/167 , A61K31/433 , A61K31/5517 , A61K2300/00
Abstract: An abuse deterrent immediate release coated reservoir solid dosage form that releases the drug at a desired rate for quick onset of action when a single unit or prescribed units of the dosage form are orally administered but exhibits a reduced rate of release when more than the prescribed number of units, are administered.
-
-
-